Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Mouse |
Host species | Goat |
Applications | ELISA,WB-Ti |
Brand: | Abnova |
Reference: | PAB7393 |
Product name: | COL4A3BP polyclonal antibody |
Product description: | Goat polyclonal antibody raised against synthetic peptide of COL4A3BP. |
Gene id: | 10087 |
Gene name: | COL4A3BP |
Gene alias: | CERT|CERTL|FLJ20597|GPBP|STARD11 |
Gene description: | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
Immunogen: | A synthetic peptide corresponding to human COL4A3BP. |
Immunogen sequence/protein sequence: | DHDSAPLNNRC |
Protein accession: | NP_005704.1;NP_112729.1 |
Form: | Liquid |
Concentration: | 0.5 mg/mL |
Recommend dilutions: | ELISA (1:32000) Western Blot (0.5-1.5 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Goat |
Antigen species / target species: | Human |
Specificity: | This antibody is expected to recognize both reported isoforms (NP_005704.1 and NP_112729.1). |
Reactivity: | Mouse |
Application image: | ![]() |
Application image note: | COL4A3BP polyclonal antibody (Cat # PAB7393) (0.5 ug/mL) staining of mouse heart lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
Applications: | ELISA,WB-Ti |
Shipping condition: | Dry Ice |
Publications: | Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs.Swanton C, Marani M, Pardo O, Warne PH, Kelly G, Sahai E, Elustondo F, Chang J, Temple J, Ahmed AA, Brenton JD, Downward J, Nicke B. Cancer Cell. 2007 Jun;11(6):498-512. |